Peter Hafkemeyer

708 total citations
22 papers, 604 citations indexed

About

Peter Hafkemeyer is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Peter Hafkemeyer has authored 22 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Peter Hafkemeyer's work include HIV/AIDS drug development and treatment (11 papers), Hepatitis B Virus Studies (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Peter Hafkemeyer is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), Hepatitis B Virus Studies (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Peter Hafkemeyer collaborates with scholars based in Germany, United States and Switzerland. Peter Hafkemeyer's co-authors include Saibal Dey, Ulrich Hübscher, Michael M. Gottesman, Elena Ferrari, Thomas Weiser, Max Gassmann, Pia Thömmes, Hubert E. Blum, Ira Pastan and Suresh V. Ambudkar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Peter Hafkemeyer

22 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Hafkemeyer Germany 14 300 252 144 86 85 22 604
J. H. Beijnen Netherlands 17 320 1.1× 295 1.2× 100 0.7× 43 0.5× 133 1.6× 40 797
Daniel Vitt Germany 20 435 1.4× 137 0.5× 84 0.6× 36 0.4× 205 2.4× 45 906
Kamil Nosol Switzerland 9 267 0.9× 272 1.1× 111 0.8× 56 0.7× 43 0.5× 14 543
Masakazu Kakuni Japan 15 256 0.9× 179 0.7× 39 0.3× 51 0.6× 165 1.9× 31 674
Yong-Lian Zhu United States 14 513 1.7× 159 0.6× 153 1.1× 14 0.2× 109 1.3× 22 804
J P Shaw United States 11 348 1.2× 118 0.5× 224 1.6× 23 0.3× 133 1.6× 13 894
Olaf Kinzel Italy 17 389 1.3× 345 1.4× 122 0.8× 13 0.2× 203 2.4× 42 964
Jacintha Shenton United States 13 253 0.8× 153 0.6× 73 0.5× 31 0.4× 54 0.6× 18 753
Joel V. Tuttle United States 18 889 3.0× 113 0.4× 327 2.3× 55 0.6× 445 5.2× 22 1.3k
E. Nieves United States 11 231 0.8× 139 0.6× 55 0.4× 22 0.3× 77 0.9× 15 829

Countries citing papers authored by Peter Hafkemeyer

Since Specialization
Citations

This map shows the geographic impact of Peter Hafkemeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hafkemeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hafkemeyer more than expected).

Fields of papers citing papers by Peter Hafkemeyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hafkemeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hafkemeyer. The network helps show where Peter Hafkemeyer may publish in the future.

Co-authorship network of co-authors of Peter Hafkemeyer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hafkemeyer. A scholar is included among the top collaborators of Peter Hafkemeyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hafkemeyer. Peter Hafkemeyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoffmann, Marco, Mirjam B. Zeisel, Nikolaus Jilg, et al.. (2009). Toll-Like Receptor 2 Senses Hepatitis C Virus Core Protein but Not Infectious Viral Particles. Journal of Innate Immunity. 1(5). 446–454. 21 indexed citations
2.
Hafkemeyer, Peter, et al.. (2008). Pseudomonas exotoxin antisense RNA selectively kills hepatitis B virus infected cells. World Journal of Gastroenterology. 14(18). 2810–2810. 3 indexed citations
3.
Schwacha, H, H.E. Blum, & Peter Hafkemeyer. (2008). Endoscopic therapy of gallstones ileus. Endoscopy. 40(S 02). E185–E186. 3 indexed citations
4.
Schneider, Matthias, et al.. (2007). Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-ABCC2 antisense constructs. Cancer Gene Therapy. 14(11). 875–884. 41 indexed citations
5.
Hafkemeyer, Peter, et al.. (2003). Allosteric Modulation of Human P-glycoprotein. Journal of Biological Chemistry. 278(20). 18132–18139. 77 indexed citations
6.
Schneider, Michaela, et al.. (2002). Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-MDR1 ribozymes. Hepatology. 36(4). 874–884. 38 indexed citations
7.
Brinkmann, Ulrich, Andrea Keppler‐Hafkemeyer, & Peter Hafkemeyer. (2001). Recombinant immunotoxins for cancer therapy. Expert Opinion on Biological Therapy. 1(4). 693–702. 8 indexed citations
8.
Uemura, Masahito, Wolf‐Dieter Lehmann, Helmut K. Seitz, et al.. (2000). Enhanced urinary excretion of cysteinyl leukotrienes in patients with acute alcohol intoxication. Gastroenterology. 118(6). 1140–1148. 8 indexed citations
9.
Hafkemeyer, Peter, Thomas Licht, Ira Pastan, & Michael M. Gottesman. (2000). Chemoprotection of Hematopoietic Cells by a Mutant P-Glycoprotein Resistant to a Potent Chemosensitizer of Multidrug-Resistant Cancers. Human Gene Therapy. 11(4). 555–565. 13 indexed citations
10.
Hafkemeyer, Peter, Ulrich Brinkmann, Michael M. Gottesman, & Ira Pastan. (1999). Apoptosis Induced by Pseudomonas Exotoxin: A Sensitive and Rapid Marker for Gene Delivery in Vivo. Human Gene Therapy. 10(6). 923–934. 19 indexed citations
11.
Dey, Saibal, Peter Hafkemeyer, Ira Pastan, & Michael M. Gottesman. (1999). A Single Amino Acid Residue Contributes to Distinct Mechanisms of Inhibition of the Human Multidrug Transporter by Stereoisomers of the Dopamine Receptor Antagonist Flupentixol. Biochemistry. 38(20). 6630–6639. 47 indexed citations
12.
13.
Hafkemeyer, Peter, Saibal Dey, Suresh V. Ambudkar, et al.. (1998). Contribution to Substrate Specificity and Transport of Nonconserved Residues in Transmembrane Domain 12 of Human P-Glycoprotein. Biochemistry. 37(46). 16400–16409. 64 indexed citations
14.
Offensperger, W B, Silke Offensperger, Andrea Keppler‐Hafkemeyer, Peter Hafkemeyer, & Hubert E. Blum. (1996). Antiviral activities of penciclovir and famciclovir on duck hepatitis B virus in vitro and in vivo.. PubMed. 1(3). 141–6. 5 indexed citations
15.
Hafkemeyer, Peter, Andrea Keppler‐Hafkemeyer, Martin von Janta‐Lipinski, et al.. (1996). Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo. Antimicrobial Agents and Chemotherapy. 40(3). 792–794. 13 indexed citations
16.
Hafkemeyer, Peter, et al.. (1994). Excessive iron storage in a patient with Wilson's disease. Journal of Molecular Medicine. 72(2). 134–136. 23 indexed citations
17.
Uemura, Masahito, Ulrike Buchholz, Hideyuki Kojima, et al.. (1994). Cysteinyl Leukotrienes in the Urine of Patients With Liver Diseases. Hepatology. 20(4). 804–812. 29 indexed citations
18.
Hafkemeyer, Peter, K Neftel, Reinhard Hobi, et al.. (1991). HP 0.35, a cephalosporin degradation product is a specific inhibitor of lentiviral RNAses H. Nucleic Acids Research. 19(15). 4059–4065. 20 indexed citations
19.
Weiser, Thomas, Max Gassmann, Pia Thömmes, et al.. (1991). Biochemical and functional comparison of DNA polymerases alpha, delta, and epsilon from calf thymus. Journal of Biological Chemistry. 266(16). 10420–10428. 131 indexed citations
20.
Hafkemeyer, Peter, et al.. (1990). HIV-reverse transcriptase and human DNA polymerase alpha share amino acid sequence homologies to bacterial penicillin-binding proteins.. PubMed. 12(1). 43–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. H. Beijnen Breakdown of academic impact, for papers by Daniel Vitt Breakdown of academic impact, for papers by Kamil Nosol Breakdown of academic impact, for papers by Masakazu Kakuni Breakdown of academic impact, for papers by Yong-Lian Zhu Breakdown of academic impact, for papers by J P Shaw Breakdown of academic impact, for papers by Olaf Kinzel Breakdown of academic impact, for papers by Jacintha Shenton Breakdown of academic impact, for papers by Joel V. Tuttle Breakdown of academic impact, for papers by E. Nieves
Rankless by CCL
2026